Cardiovascular Renal Metabolic

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
Semaglutide Modulates Key Pathways to Resolve MASH, Proteomic Analysis Reveals

Radcliffe CVRM

Andrew JS Coats, Stefan Anker

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s

Jose Lopez, Tracy Makuvire, Jonathan D Davis, et al

Read time: 26m 29s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

Nicolas M Van Mieghem

Watch time: 14m 12s (23 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s

Articles

Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up

Wolfgang Herrmann

,

Rima Obeid

,

Citation:

US Cardiology 2009;6(1):36–40

DOI:

https://doi.org/10.15420/usc.2009.6.1.36
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 57
  • Downloads: Downloads 0

Prevention of Cardiovascular Risk in Diabetic Patients - An Update

Peter M Nilsson

,

Citation:

US Cardiology 2007;4(2):19–21

DOI:

https://doi.org/10.15420/usc.2007.4.2.19
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 80
  • Downloads: Downloads 1

Effect of Pioglitazone Compared with Glimepiride on Carotid Intima-media Thickness in Type 2 Diabetes

Theodore Mazzone

,

Citation:

US Cardiology 2007;4(1):25–30

DOI:

https://doi.org/10.15420/usc.2007.4.1.25
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 46
  • Downloads: Downloads 1

Detection of Silent Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus

Frans J Th Wackers

,

Janice A Davey

,

Citation:

US Cardiology 2005;2(1):1-4

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 117
  • Downloads: Downloads 5